Evaluation of the CONVIVO System
Recruiting now · Not applicable
Conditions studied: Glioblastoma, Glial Tumor, Brain Metastases, Meningioma, Schwannoma, Pituitary Tumor
In brief
The primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnormal tissue in vivo during brain tumor surgery. The interpretation of intraoperative images obtained in situ will be tested against conventional histologic evaluation of targeted biopsies from imaged tissue. The study team hypothesize that there will be a high degree of correlation between images obtained with the CONVIVO system and conventional histologic interpretation.
Key facts
- Study ID
- NCT05139277
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 30
- Starts
- 2022-06-28
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-02-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (age>18)
- Adults presenting with suspected intracranial gliomas (including glioblastoma), cerebral metastasis, meningiomas, acoustic neuromas, and pituitary adenomas, who are surgical candidates
- Adults able to provide informed consent.
You may not qualify if…
- Pregnancy
- Children (age <18 years)
- Fluorescein sodium (FNa) allergy
Where it is running
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.